Prognostic relevance of serum hyaluronan levels in patients with breast cancer.

2.50
Hdl Handle:
http://hdl.handle.net/10541/109657
Title:
Prognostic relevance of serum hyaluronan levels in patients with breast cancer.
Authors:
Ponting, J; Howell, Anthony ( 0000-0002-6233-719X ) ; Pye, David A; Kumar, Shant
Abstract:
The serum hyaluronan (HA) level of 238 women with breast cancer was measured by means of a specific radiometric assay. The results show no significant increase in serum HA when compared to levels in 120 control sera. A number of prognostic factors were evaluated including stage of disease, lymph-node involvement, tumour size, histology and presence of oestrogen and progesterone receptors in the tumour. No correlation was found with serum HA concentration and we conclude that serum HA level is of no prognostic significance in breast cancer.
Affiliation:
Department of Clinical Research, Christie Hospital, Manchester, UK.
Citation:
Prognostic relevance of serum hyaluronan levels in patients with breast cancer. 1992, 52 (6):873-6 Int. J. Cancer
Journal:
International Journal of Cancer.
Issue Date:
2-Dec-1992
URI:
http://hdl.handle.net/10541/109657
DOI:
10.1002/ijc.2910520607
PubMed ID:
1459727
Type:
Article
Language:
en
ISSN:
0020-7136
Appears in Collections:
All Christie Publications ; All Paterson Institute for Cancer Research

Full metadata record

DC FieldValue Language
dc.contributor.authorPonting, Jen
dc.contributor.authorHowell, Anthonyen
dc.contributor.authorPye, David Aen
dc.contributor.authorKumar, Shanten
dc.date.accessioned2010-08-16T14:33:14Z-
dc.date.available2010-08-16T14:33:14Z-
dc.date.issued1992-12-02-
dc.identifier.citationPrognostic relevance of serum hyaluronan levels in patients with breast cancer. 1992, 52 (6):873-6 Int. J. Canceren
dc.identifier.issn0020-7136-
dc.identifier.pmid1459727-
dc.identifier.doi10.1002/ijc.2910520607-
dc.identifier.urihttp://hdl.handle.net/10541/109657-
dc.description.abstractThe serum hyaluronan (HA) level of 238 women with breast cancer was measured by means of a specific radiometric assay. The results show no significant increase in serum HA when compared to levels in 120 control sera. A number of prognostic factors were evaluated including stage of disease, lymph-node involvement, tumour size, histology and presence of oestrogen and progesterone receptors in the tumour. No correlation was found with serum HA concentration and we conclude that serum HA level is of no prognostic significance in breast cancer.en
dc.language.isoenen
dc.subjectBreast Canceren
dc.subjectCancer Stagingen
dc.subjectOestrogen Receptorsen
dc.subject.meshAdult-
dc.subject.meshAged-
dc.subject.meshAged, 80 and over-
dc.subject.meshBreast Neoplasms-
dc.subject.meshChi-Square Distribution-
dc.subject.meshFemale-
dc.subject.meshHumans-
dc.subject.meshHyaluronic Acid-
dc.subject.meshLife Tables-
dc.subject.meshLymphatic Metastasis-
dc.subject.meshMiddle Aged-
dc.subject.meshNeoplasm Staging-
dc.subject.meshPrognosis-
dc.subject.meshReceptors, Estrogen-
dc.subject.meshReceptors, Progesterone-
dc.subject.meshSurvival Analysis-
dc.titlePrognostic relevance of serum hyaluronan levels in patients with breast cancer.en
dc.typeArticleen
dc.contributor.departmentDepartment of Clinical Research, Christie Hospital, Manchester, UK.en
dc.identifier.journalInternational Journal of Cancer.en

Related articles on PubMed

All Items in Christie are protected by copyright, with all rights reserved, unless otherwise indicated.